{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:09Z","timestamp":1789609209929,"version":"build-2803163510"},"reference-count":15,"publisher":"Media Sphere Publishing House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Objective. To evaluate the efficacy and safety of the anti-CD20 monoclonal antibody divozilimab (DIV) used as an intravenous infusion at a dose of 500 mg every 24 weeks during 100 weeks for the treatment of patients with multiple sclerosis (MS), including relapsing-remitting multiple sclerosis (RRMS) and secondary progressive MS (SPMS) with relapses. Material and methods. The multicenter, randomized, double-blind and double-masked phase III clinical trial (CT) BCD-132-4\/MIRANTIBUS (NCT05385744) included 338 adult patients with MS distributed in a 1:1 ratio into two groups: DIV 500 mg and teriflunomide (TRF) 14 mg. After screening, subjects were included in the main CT period, which consisted of two cycles of therapy over 48 weeks, then entered an additional period from weeks 49 to 100, which included three cycles of therapy. The efficacy was assessed based on the results of brain MRI and registration of data on relapses. Results. 308 subjects completed 5 therapy cycles according to the study protocol. An analysis of the effectiveness of DIV therapy over 2 years showed a persistent suppression of MRI and clinical activity of the disease in comparison with TRF, which was confirmed by all the studied MRI indicators (including CUA; total number of gadolinium-enhancing (GdE) lesions on T1-weighted scans ; number of new or enlarged lesions on T2-weighted scans; lesions volume change on T2-weighted scans; change in the volume of hypointense lesions on T1-weighted scans). The use of DIV was associated with a statistically significant decrease in ARR compared to TRF (p=0.0001). The ARR in the DIV group was 0.057, in the TRF group \u2014 0.164 with 95% confidential interval for the frequency ratio [0.202; 0.593]. The incidence of GdE lesions on T1-weighted scans in the DIV group was significantly lower than in the TRF group. The average number of such lesions was 0.0\u00b10.08 and 1.0\u00b14.46 in the DIV and TRF groups, respectively (p&lt;0.0001). Progression of EDSS was detected in 18 (10.7%) and 36 (21.3%) patients in the DIV and TRF groups, respectively (p=0.0075). The proportion of patients with relapses was 11.2% (n=19) in the DIV group and 23.1% (n=39) in the TRF group (p=0.0039). In the subpopulation of patients with SPMS, no cases of increase in EDSS were detected, and not a single case of exacerbation was recorded over 2 years of using DIV. Also, DIV has shown a favorable safety profile. Among the adverse reactions (AR), infusion reactions and laboratory abnormalities, such as a decrease in the number of leukocytes, neutrophils, and lymphocytes, were most often recorded. Identified AR were expected, had mild to moderate severity, and resolved without any negative consequences. Conclusion. The results of the BCD-132-4\/MIRANTIBUS CT indicate a high sustained efficacy and safety of long-term use of DIV in comparison with TRF during 2 years of therapy.<\/jats:p>","DOI":"10.17116\/jnevro202412404186","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T13:43:43Z","timestamp":1714225423000},"page":"86","source":"Crossref","is-referenced-by-count":12,"title":["Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4\/MIRANTIBUS"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-3250","authenticated-orcid":false,"given":"A.N.","family":"Boyko","sequence":"first","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]},{"name":"Federal Center of Brain and Neurotechnologies","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4140-3223","authenticated-orcid":false,"given":"V.M.","family":"Alifirova","sequence":"additional","affiliation":[{"name":"Siberian State Medical University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-8624","authenticated-orcid":false,"given":"I.G.","family":"Lukashevich","sequence":"additional","affiliation":[{"name":"City Clinical Hospital No. 1","place":["Chelyabinsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7093-9548","authenticated-orcid":false,"given":"Z.A.","family":"Goncharova","sequence":"additional","affiliation":[{"name":"Rostov State Medical University","place":["Rostov-on-Don, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3092-5381","authenticated-orcid":false,"given":"I.V.","family":"Greshnova","sequence":"additional","affiliation":[{"name":"Ulyanovsk Regional Clinical Hospital","place":["Ulyanovsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-1512","authenticated-orcid":false,"given":"L.G.","family":"Zaslavsky","sequence":"additional","affiliation":[{"name":"Leningrad Regional Clinical Hospital","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-7317","authenticated-orcid":false,"given":"S.V.","family":"Kotov","sequence":"additional","affiliation":[{"name":"Vladimirsky Moscow Regional Research Clinical Institute","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1255-8525","authenticated-orcid":false,"given":"N.A.","family":"Malkova","sequence":"additional","affiliation":[{"name":"State Novosibirsk Regional Clinical Hospital","place":["Novosibirsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-0881","authenticated-orcid":false,"given":"G.N.","family":"Mishin","sequence":"additional","affiliation":[{"name":"Pyatigorsk City Clinical Hospital No. 2","place":["Pyatigorsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-053X","authenticated-orcid":false,"given":"E.V.","family":"Parshina","sequence":"additional","affiliation":[{"name":"Semashko Nizhny Novgorod Regional Clinical Hospital","place":["Nizhny Novgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2594-461X","authenticated-orcid":false,"given":"I.Ye.","family":"Poverennova","sequence":"additional","affiliation":[{"name":"Seredavin Samara Regional Clinical Hospital","place":["Samara, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4776-2999","authenticated-orcid":false,"given":"L.N.","family":"Prakhova","sequence":"additional","affiliation":[{"name":"N. Bechtereva Institute of the Human Brain","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9293-5932","authenticated-orcid":false,"given":"S.A.","family":"Sivertseva","sequence":"additional","affiliation":[{"name":"Medical and Sanitary unit \u00abNeftyanik\u00bb","place":["Tyumen, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-4529","authenticated-orcid":false,"given":"I.V.","family":"Smagina","sequence":"additional","affiliation":[{"name":"Regional Clinical Hospital","place":["Barnaul, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6715-8203","authenticated-orcid":false,"given":"N.A.","family":"Totolyan","sequence":"additional","affiliation":[{"name":"Pavlov First Saint Petersburg State Medical University","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-7308","authenticated-orcid":false,"given":"Yu.V.","family":"Trinitatsky","sequence":"additional","affiliation":[{"name":"Rostov Regional Clinical Hospital","place":["Rostov-on-Don, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-7392","authenticated-orcid":false,"given":"T.N.","family":"Trushnikova","sequence":"additional","affiliation":[{"name":"Wagner Perm State Medical University","place":["Perm, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-6970","authenticated-orcid":false,"given":"F.A.","family":"Khabirov","sequence":"additional","affiliation":[{"name":"Republican Clinical Nerological Center","place":["Kazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-7461","authenticated-orcid":false,"given":"J.Yu.","family":"Chefranova","sequence":"additional","affiliation":[{"name":"Belgorod Regional Clinical Hospital of St. Joasaph","place":["Belgorod, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1715-0465","authenticated-orcid":false,"given":"S.G.","family":"Shchur","sequence":"additional","affiliation":[{"name":"Municipal Filatov Clinical Hospital No. 15","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5624-240X","authenticated-orcid":false,"given":"V.A.","family":"Dudin","sequence":"additional","affiliation":[{"name":"Center for Cardiology and Neurology","place":["Kirov, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-5043","authenticated-orcid":false,"given":"D.V.","family":"Pokhabov","sequence":"additional","affiliation":[{"name":"Federal Siberian Scientific and Clinical Center","place":["Krasnoyarsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-3377","authenticated-orcid":false,"given":"A.V.","family":"Artemeva","sequence":"additional","affiliation":[{"name":"JSC BIOCAD","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-6911","authenticated-orcid":false,"given":"A.V.","family":"Eremeeva","sequence":"additional","affiliation":[{"name":"JSC BIOCAD","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5463-1022","authenticated-orcid":false,"given":"Yu.N.","family":"Linkova","sequence":"additional","affiliation":[{"name":"JSC BIOCAD","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8499-2232","authenticated-orcid":false,"given":"A.V.","family":"Zinkina-Orikhan","sequence":"additional","affiliation":[{"name":"JSC BIOCAD","place":["St. Petersburg, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202412404186-1","unstructured":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):232-327"},{"key":"key-10.17116\/jnevro202412404186-2","unstructured":"The Multiple Sclerosis International Federation (MSIF). Atlas of MS, 3rd Edition: Mapping multiple sclerosis around the world key epidemiology findings, 2020.  https:\/\/www.msif.org\/wp-content\/uploads\/2020\/10\/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf"},{"key":"key-10.17116\/jnevro202412404186-3","doi-asserted-by":"crossref","unstructured":"Lassmann H, Br\u00fcck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17(2):210-218","DOI":"10.1111\/j.1750-3639.2007.00064.x"},{"key":"key-10.17116\/jnevro202412404186-4","doi-asserted-by":"crossref","unstructured":"Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907-911","DOI":"10.1212\/WNL.46.4.907"},{"key":"key-10.17116\/jnevro202412404186-5","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2019-3-16-25"},{"key":"key-10.17116\/jnevro202412404186-6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30067-3"},{"key":"key-10.17116\/jnevro202412404186-7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24895"},{"key":"key-10.17116\/jnevro202412404186-8","doi-asserted-by":"crossref","unstructured":"Arneth BM. Impact of B cells to the pathophysiology of multiple sclerosis. J Neuroinflammation. 2019;16(1):128","DOI":"10.1186\/s12974-019-1517-1"},{"key":"key-10.17116\/jnevro202412404186-9","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20191191087"},{"key":"key-10.17116\/jnevro202412404186-10","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312304137"},{"key":"key-10.17116\/jnevro202412404186-11","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312307243"},{"key":"key-10.17116\/jnevro202412404186-12","unstructured":"ICH GCP Good Clinical Practice Guidelines. (In Russ.). https:\/\/ichgcp.net\/ru"},{"key":"key-10.17116\/jnevro202412404186-13","unstructured":"Decision of the Council of the Eurasian Economic Commission No. 79 of November 3, 2016 on the approval of the Rules of Good Clinical Practice of the Eurasian Economic Union. (In Russ.). https:\/\/docs.eaeunion.org\/docs\/ru-ru\/01411924\/cncd_21112016_79"},{"key":"key-10.17116\/jnevro202412404186-14","doi-asserted-by":"publisher","DOI":"10.1016\/S474-4422(17)30470-2"},{"key":"key-10.17116\/jnevro202412404186-15","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Published: November 27, 2017.  https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:01:19Z","timestamp":1745384479000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/4\/1199772982024041086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,27]]}},"alternative-id":["10.17116\/jnevro202412404186"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202412404186","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}